PLA2R1 and autoimmune disease: The disease can be primary (autoantibodies against PLA2R/THSD7A) or secondary (associated with factors such as cancer, infection, drugs, or autoimmune diseases); this distinction has prognostic and therapeutic implications [3,15,16,17,18].